105 Participants Needed

ePRO Symptom Monitoring for Thoracic Surgery Patients

AG
Overseen ByAmanda Gentry
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: UNC Lineberger Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests a system where thoracic surgery patients fill out electronic surveys about their health after surgery. If any serious issues are reported, doctors are alerted right away. This aims to catch problems early and reduce severe complications.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment ePRO Monitoring for thoracic surgery patients?

Research shows that using electronic patient-reported outcome (ePRO) systems for symptom monitoring can help detect complications early and improve symptom control after surgery, as seen in studies involving cancer-related surgeries and lung cancer patients.12345

Is ePRO symptom monitoring safe for thoracic surgery patients?

Electronic patient-reported outcome (ePRO) systems are used to monitor symptoms in real-time after surgery, which can help detect complications early and improve patient safety. While specific safety data for thoracic surgery patients using ePRO is not detailed, these systems are generally considered safe for monitoring symptoms in various surgical settings.16789

How does ePRO Monitoring differ from other treatments for thoracic surgery patients?

ePRO Monitoring is unique because it uses electronic patient-reported outcomes to continuously track symptoms and vital signs, allowing for real-time monitoring and early intervention if needed. This approach is different from traditional methods that may rely on less frequent, manual checks and can help prevent complications by alerting clinicians to changes in a patient's condition more quickly.1011121314

Research Team

GM

Gita Mody, MD, MPH

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for adults who've had or will have major thoracic surgery, can complete surveys in English or Spanish, and are not pregnant. Excluded are those with minor surgeries, mental conditions affecting consent, prisoners, or if the surgery didn't happen within 3 months after consent.

Inclusion Criteria

I can complete a symptom survey online, by phone, or with a research team member.
I am planning to have or have had major chest surgery within the last 30 days.

Exclusion Criteria

Patients currently incarcerated
Pregnant patients
I have only had minor chest surgeries, like a bronchoscopy.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Implementation of ePRO monitoring for thoracic surgery patients

3 months
Remote monitoring via web-based or telephone surveys

Monitoring

Participants are monitored using ePRO surveys to track symptoms and trigger alerts

90 days
Continuous remote monitoring

Follow-up

Participants are monitored for safety and effectiveness after the main monitoring phase

4 weeks

Treatment Details

Interventions

  • ePRO Monitoring
Trial Overview The study tests a health tech intervention called ePRO monitoring. It involves patients reporting their symptoms and physical functioning through electronic surveys post-thoracic surgery, which then automatically alert providers to any concerning responses.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ePRO monitoringExperimental Treatment1 Intervention
Thoracic surgery patients will be enrolled in ePRO monitoring using web-based or telephone surveys.

Find a Clinic Near You

Who Is Running the Clinical Trial?

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

Trials
377
Recruited
95,900+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

A pilot study involving 40 patients who underwent cancer-related upper gastrointestinal surgery demonstrated that an electronic patient-reported outcome (ePRO) system is feasible and acceptable for real-time symptom monitoring after discharge.
The ePRO system effectively triggered tailored self-management advice and clinician alerts based on patient-reported symptoms, indicating its potential to enhance patient safety and support recovery, though further research is needed to assess its overall impact.
A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.Richards, HS., Blazeby, JM., Portal, A., et al.[2021]
In a study of 1041 patients undergoing pulmonary cancer surgery, the presence of any postoperative adverse event, even minor ones, significantly increased the likelihood of a prolonged hospital stay, with higher severity events leading to even longer stays.
Factors such as lower lung diffusion capacity and the use of open thoracotomy were also associated with longer hospital stays, highlighting the importance of preoperative assessments and surgical approaches in patient outcomes.
All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.Zhang, Z., Mostofian, F., Ivanovic, J., et al.[2022]
Standardized data collection of postoperative adverse events in thoracic surgery can significantly enhance patient care by documenting and informing practices to reduce complications.
Engaging surgeons in audit and feedback based on this data can lead to consensus recommendations that improve patient outcomes following high-risk surgeries.
Standardized Postoperative Adverse Event Data Collection to Document, Inform, and Improve Patient Care.Shamji, FM., Gingrich, M., Anstee, C., et al.[2021]

References

A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. [2021]
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. [2022]
Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients. [2022]
Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial. [2023]
Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol. [2020]
Impact of Adverse Events and Length of Stay on Patient Experience After Lung Cancer Resection. [2022]
All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection. [2022]
Standardized Postoperative Adverse Event Data Collection to Document, Inform, and Improve Patient Care. [2021]
Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Exercise capacity of thoracotomy patients in the early postoperative period. [2019]
Insights into postoperative respiration by using continuous wireless monitoring of respiratory rate on the postoperative ward: a cohort study. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Evaluation of a respiratory rate monitor in postsurgical patients. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
A clinical evaluation of pulse oximetry during thoracic surgery. [2019]
Vital sign monitoring with continuous pulse oximetry and wireless clinical notification after surgery (the VIGILANCE pilot study)-a randomized controlled pilot trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security